TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

23 insiders · 54 transactions

25.8×

Richard Francis holds 25.8 times base salary in stock. $43.86M of shares against $1.70M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Francis last reported holding, valued at $37.25, the price Ordinary Shares was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Francis Richard D

President and CEO

—

$31.26M (7) scheduled

−$31.26M

1,177,529

0.1010%

$43.86M

+855.1%

Kalif Eliyahu Sharon

EVP, Chief Financial Officer

—

$20.73M (3) scheduled

−$20.73M

65,621

0.0056%

$2.44M

−67.8%

Sabag Mark

See "Remarks"

—

$13.15M (4)

−$13.15M

80,760

0.0069%

$3.01M

−78.9%

Daniell Richard

EVP, Europe Commercial

—

$12.08M (8) scheduled

−$12.08M

55,755

0.0048%

$2.08M

—

MIGNONE ROBERTO

Director

—

$8.46M (3)

−$8.46M

487,407

0.0418%

$18.16M

−54.7%

Hughes Eric A

See "Remarks"

—

$4.17M (5) scheduled

−$4.17M

134,877

0.0116%

$5.02M

—

Fox Christine

EVP, U.S. Commercial

—

$2.75M (5)

−$2.75M

63,647

0.0055%

$2.37M

—

Lippman Evan

EVP, Business Development

—

$2.16M (3) scheduled

−$2.16M

25,591

0.0022%

$953.26K

—

Weiss Amir

Chief Accounting Officer

—

$1.41M (5)

−$1.41M

13,071

0.0011%

$486.89K

+152.4%

Shields Matthew

EVP, Global Operations

—

$1.40M (3) scheduled

−$1.40M

0.0000%

$0.00

—

Jover Placid

See "Remarks"

—

$895.46K (2) scheduled

−$895.46K

6,774

0.0006%

$252.33K

—

Savage Brian

Interim Chief Legal Officer

—

$163.76K (4) scheduled

−$163.76K

10,914

0.0009%

$406.55K

+1,377%

Satchi-Fainaro Ronit

Director

—

$15.46K (1)

−$15.46K

111,986

0.0096%

$4.17M

+26.9%

Zaks Tal Zvi

Director

—

$592.71 (1)

−$592.71

73,247

0.0063%

$2.73M

+49.1%

Elstein Amir

Director

—

2,118,455

0.1818%

$78.91M

+1.2%

BARER SOL J

Director

—

448,011

0.0384%

$16.69M

+9.5%

LIEBERMAN GERALD M

Director

—

130,149

0.0112%

$4.85M

+22.8%

Crane Rosemary A

Director

—

127,739

0.0110%

$4.76M

+23.3%

Nisen Perry

Director

—

119,807

0.0103%

$4.46M

+25.2%

Vergis Janet S.

Director

—

73,697

0.0063%

$2.75M

+15.0%

Shalev Varda

Director

—

22,504

0.0019%

$838.27K

+74.8%

Lichtenstein Chen

Director

—

19,296

0.0017%

$718.78K

—

McAvoy David R.

EVP, Chief Legal Officer

—

13,027

0.0011%

$485.26K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Satchi-Fainaro Ronit

21 Aug 2026

Director

Sell

415

$37.25

$15.46K

Zaks Tal Zvi

5 Aug 2026

Director

Sell

$34.87

$592.71

Shields Matthew

18 Jun 2026

EVP, Global Operations

Sell

9,989

$32.19

$321.55K

Weiss Amir

6 May 2026

Chief Accounting Officer

Sell

10,679

$36.00

$384.44K

Daniell Richard

5 May 2026

EVP, Europe Commercial

Sell

30,000

$35.40

$1.06M

Sabag Mark

1 May 2026

See "Remarks"

Sell

144,180

$34.99

$5.05M

Fox Christine

30 Apr 2026

EVP, U.S. Commercial

Sell

21,258

$35.31

$750.62K

Sabag Mark

17 Mar 2026

See "Remarks"

Sell

62,102

$30.14

$1.87M

MIGNONE ROBERTO

16 Dec 2025

Director

Sell indirect

77,400

$30.24

$2.34M

Weiss Amir

16 Dec 2025

Chief Accounting Officer

Sell

12,300

$30.20

$371.50K

MIGNONE ROBERTO

26 Nov 2025

Director

Sell indirect

50,000

$26.03

$1.30M

Fox Christine

14 Nov 2025

EVP, Head of U.S. Commercial

Sell

30,000

$25.11

$753.32K

Weiss Amir

6 Nov 2025

Chief Accounting Officer

Sell

12,300

$24.44

$300.56K

MIGNONE ROBERTO

6 Nov 2025

Director

Sell indirect

200,000

$24.11

$4.82M

Show all 54 transactions →

TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

Individual transactions

What was left out